Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

C9orf43 Inhibitors

Staurosporine stands as a prominent kinase inhibitor, exerting influence over a spectrum of protein kinases which could have downstream regulatory effects on C9orf43 activity. By inhibiting these kinases, staurosporine indirectly modulates various signaling cascades within cells, which, in turn, might affect the functionality or regulation of C9orf43. Similarly, LY294002 and Wortmannin, both phosphoinositide 3-kinases (PI3K) inhibitors, disrupt critical cellular signaling pathways by preventing the phosphorylation of PI3K substrates, thereby potentially altering the cellular context in which C9orf43 operates. In the realm of the mitogen-activated protein kinase (MAPK) pathway, U0126 and PD98059, both MEK inhibitors, intervene in the kinase cascade that is pivotal for cell division and differentiation, which could intersect with the biological pathways involving C9orf43. Rapamycin, an mTOR inhibitor, adds another layer of complexity by influencing cellular growth and metabolism, processes that are essential for the proper functioning of numerous proteins, possibly including C9orf43.

SB203580, a p38 MAP kinase inhibitor, specifically targets the inflammatory signaling pathways, which can have far-reaching implications on protein functions across the cell, including those associated with C9orf43. The c-Jun N-terminal kinase (JNK) pathway, implicated in the cellular stress response, is targeted by SP600125, a JNK inhibitor, providing a means to potentially alter the cellular environment of C9orf43. Beyond the signaling pathways, epigenetic modulators like Trichostatin A, a histone deacetylase inhibitor, and 5-Azacytidine, a DNA methyltransferase inhibitor, can broadly impact gene expression profiles, which could include the modulation of C9orf43 expression. Brefeldin A, by disrupting the Golgi apparatus, may indirectly influence proteins involved in trafficking and processing, including C9orf43. Thapsigargin, through its inhibition of the SERCA pump, perturbs calcium homeostasis, a fundamental aspect of cell biology with potential ramifications for a multitude of proteins and cellular processes wherein C9orf43 may be implicated.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Inhibits protein kinases which may downstream regulate C9orf43 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor, alters signaling pathways that could intersect with C9orf43 functions.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

MEK inhibitor, affects MAPK pathway which might modulate proteins interacting with C9orf43.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor, can influence cellular processes that C9orf43 could be implicated in.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAP kinase inhibitor, alters inflammatory response pathways potentially linked to C9orf43.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor, similar to LY294002 in affecting pathways that C9orf43 could partake in.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, can modulate stress response pathways that might affect C9orf43's role in the cell.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor, similar to U0126, with possible effects on pathways involving C9orf43.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Histone deacetylase inhibitor, can alter gene expression profiles potentially including C9orf43.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor, can change DNA methylation status, possibly affecting C9orf43 expression.